Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 3
2009 6
2010 7
2011 11
2012 5
2013 3
2014 4
2015 6
2016 9
2017 11
2018 7
2019 13
2020 6
2021 5
2022 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial.
Facon T, Dimopoulos MA, Meuleman N, Belch A, Mohty M, Chen WM, Kim K, Zamagni E, Rodriguez-Otero P, Renwick W, Rose C, Tempescul A, Boyle E, Manier S, Attal M, Moreau P, Macro M, Leleu X, Lorraine Chretien M, Ludwig H, Guo S, Sturniolo M, Tinel A, Silvia Monzini M, Costa B, Houck V, Hulin C, Yves Mary J. Facon T, et al. Among authors: tempescul a. Leukemia. 2020 Jan;34(1):224-233. doi: 10.1038/s41375-019-0539-0. Epub 2019 Aug 19. Leukemia. 2020. PMID: 31427722 Free PMC article. Clinical Trial.
Complement System: a Neglected Pathway in Immunotherapy.
Bordron A, Bagacean C, Tempescul A, Berthou C, Bettacchioli E, Hillion S, Renaudineau Y. Bordron A, et al. Among authors: tempescul a. Clin Rev Allergy Immunol. 2020 Apr;58(2):155-171. doi: 10.1007/s12016-019-08741-0. Clin Rev Allergy Immunol. 2020. PMID: 31144209 Review.
A case of IgE myeloma transformed into IgE-producing plasma cell leukaemia.
Galakhoff N, Leven C, Eveillard JR, Tempescul A, Kerspern H, Aubron C, Buors C, Lippert É, Carré JL, Padelli M. Galakhoff N, et al. Among authors: tempescul a. Biochem Med (Zagreb). 2020 Feb 15;30(1):010801. doi: 10.11613/BM.2020.010801. Epub 2019 Dec 15. Biochem Med (Zagreb). 2020. PMID: 31839726 Free PMC article.
Isolated Cardiac Richter Syndrome: a Case Report.
Zdrenghea M, Bagacean C, Renaudineau Y, Salaun PY, Marin H, Pop D, Tempescul A. Zdrenghea M, et al. Among authors: tempescul a. Ann Hematol. 2017 Jan;96(1):147-149. doi: 10.1007/s00277-016-2834-4. Epub 2016 Oct 3. Ann Hematol. 2017. PMID: 27696201 No abstract available.
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Kater AP, Arslan Ö, Demirkan F, Herishanu Y, Ferhanoglu B, Diaz MG, Leber B, Montillo M, Panayiotidis P, Rossi D, Skarbnik A, Tempescul A, Turgut M, Mellink CH, van der Kevie-Kersemaekers AF, Lanham S, Sale B, Del Rio L, Popovic R, Chyla BJ, Busman T, Komlosi V, Wang X, Sail K, Pena GE, Vizkelety T, Forconi F. Kater AP, et al. Among authors: tempescul a. Lancet Oncol. 2024 Apr;25(4):463-473. doi: 10.1016/S1470-2045(24)00070-6. Epub 2024 Mar 8. Lancet Oncol. 2024. PMID: 38467131 Free article. Clinical Trial.
Rapid and complete response to idelalisib in a case of Richter syndrome.
Bagacean C, Zdrenghea M, Saad H, Berthou C, Renaudineau Y, Tempescul A. Bagacean C, et al. Among authors: tempescul a. Onco Targets Ther. 2019 Feb 13;12:1181-1184. doi: 10.2147/OTT.S187459. eCollection 2019. Onco Targets Ther. 2019. PMID: 30863085 Free PMC article.
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Gressin R, Daguindau N, Tempescul A, Moreau A, Carras S, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Pignon JM, Corm S, Banos A, Mounier C, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouadallah K, Amorin S, Garidi R, Voillat L, Joly B, Celigny PS, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Le Gouill S, Callanan MB; Lymphoma Study Association. Gressin R, et al. Among authors: tempescul a. Haematologica. 2019 Jan;104(1):138-146. doi: 10.3324/haematol.2018.191429. Epub 2018 Aug 31. Haematologica. 2019. PMID: 30171024 Free PMC article. Clinical Trial.
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).
Manson G, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Regny C, Bouabdallah K, Chauchet A, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Dercle L, Brice P, Houot R; Lymphoma Study Association (LYSA). Manson G, et al. Among authors: tempescul a. Br J Haematol. 2022 Jul;198(1):203-206. doi: 10.1111/bjh.18198. Epub 2022 Apr 21. Br J Haematol. 2022. PMID: 35445392 Free article. No abstract available.
79 results